Fortune Electric Co., Ltd. (TPE:1519)

Elevation Oncology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,017	2,481	1,737	595.63	168.98	170.82
Short-Term Investments	38.88	25	200.77	223.1	92.45	-
Cash & Short-Term Investments	5,056	2,506	1,938	818.73	261.43	170.82
Cash Growth	44.55%	29.29%	136.74%	213.17%	53.05%	15.50%
Accounts Receivable	5,623	6,989	4,506	3,600	4,080	3,302
Other Receivables	0.02	0.02	22.29	21.51	2.07	9.03
Receivables	5,623	6,989	4,528	3,621	4,082	3,312
Inventory	8,495	7,598	5,441	4,205	2,731	2,229
Prepaid Expenses	789.32	715.18	453.49	303.6	177.88	116.43
Other Current Assets	409.41	330.14	205.44	169.13	90.81	626.03
Total Current Assets	20,373	18,138	12,567	9,118	7,343	6,454
Property, Plant & Equipment	3,060	2,820	2,223	2,106	2,135	2,102
Long-Term Investments	507.53	261.79	291.08	314.79	318.04	45.09
Other Intangible Assets	60.6	67.01	66.43	56.53	41.27	31.21
Long-Term Deferred Tax Assets	81.65	78.35	30.5	38.15	35.61	47.12
Other Long-Term Assets	347.47	504.38	68.55	67.56	48.98	13.61
Total Assets	24,430	21,869	15,247	11,700	9,922	8,692
Accounts Payable	3,715	4,350	3,343	2,150	2,351	2,061
Accrued Expenses	1,199	1,785	963.37	387.46	285.49	269.37
Short-Term Debt	500	35	239.75	1,246	1,438	469.71
Current Portion of Long-Term Debt	-	-	150	791.8	-	-
Current Portion of Leases	104.27	83.87	19.62	15.54	11.31	8.37
Current Income Taxes Payable	992.97	772.05	515.78	0.02	39.85	32.31
Current Unearned Revenue	4,938	5,002	2,856	1,572	495.44	641.6
Other Current Liabilities	3,085	420.65	690.39	247.55	275.55	452.63
Total Current Liabilities	14,534	12,448	8,777	6,411	4,897	3,935
Long-Term Debt	-	-	100	720	1,202	841.8
Long-Term Leases	477.43	458	123.53	115.87	111.97	111.74
Long-Term Unearned Revenue	2,202	58.13	-	-	-	-
Long-Term Deferred Tax Liabilities	113.08	107.07	84.73	120.38	45.52	65.76
Other Long-Term Liabilities	25.74	24.25	23.37	25.74	17.33	12.38
Total Liabilities	17,353	13,096	9,114	7,435	6,403	5,145
Common Stock	2,872	2,872	2,611	2,611	2,611	2,611
Additional Paid-In Capital	87.02	87.02	86.96	86.69	3.48	1.41
Retained Earnings	4,166	5,890	3,418	1,506	902.52	950.36
Comprehensive Income & Other	-162.18	-165.75	-88.63	-59.48	-37.58	-15.35
Total Common Equity	6,962	8,683	6,026	4,144	3,479	3,547
Minority Interest	115.46	91.07	106.1	121.57	40.72	-
Shareholders' Equity	7,078	8,774	6,133	4,265	3,520	3,547
Total Liabilities & Equity	24,430	21,869	15,247	11,700	9,922	8,692
Total Debt	1,082	576.87	632.9	2,890	2,763	1,432
Net Cash (Debt)	3,974	1,929	1,305	-2,071	-2,501	-1,261
Net Cash Growth	67.71%	47.78%	-	-	-	-
Net Cash Per Share	12.56	6.10	4.12	-6.53	-7.90	-3.98
Filing Date Shares Outstanding	315.88	315.88	315.88	315.88	315.88	315.88
Total Common Shares Outstanding	315.88	315.88	315.88	315.88	315.88	315.88
Working Capital	5,839	5,689	3,789	2,707	2,446	2,519
Book Value Per Share	22.04	27.49	19.08	13.12	11.01	11.23
Tangible Book Value	6,902	8,616	5,960	4,087	3,438	3,516
Tangible Book Value Per Share	21.85	27.28	18.87	12.94	10.88	11.13
Land	635.83	635.83	635.83	635.83	635.83	635.83
Buildings	994.1	1,689	1,627	1,586	1,618	1,562
Machinery	583.04	2,242	2,151	1,991	2,089	1,895
Construction In Progress	280.35	100.87	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.